C. Tunon de Lara

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

Mila Donker, Saskia Litière, Gustavo Werutsky et al. · Journal of Clinical Oncology · 2013 · 371 citations · Full text

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer

Carine Bellera, Gaëtan MacGrogan, Marc Debled et al. · BMC Medical Research Methodology · 2010 · 367 citations · Full text

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean‐Marc Classe, Cécile Loaec, Pierre Gimbergues et al. · Breast Cancer Research and Treatment · 2018 · 257 citations

Surgical Oncology, Neoadjuvant Chemotherapy, Cancer Detection +11

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases

B. Cutuli, C. Cohen-Solal Le-Nir, D. Serin et al. · Critical Reviews in Oncology/Hematology · 2009 · 181 citations

Prognostic Factors, Surgical Oncology, Breast Oncology +8

Mammography of ductal carcinoma in situ of the breast: Review of 909 cases with radiographic–pathologic correlations

B. Barreau, Isabelle de Mascarel, Caroline Feuga et al. · European Journal of Radiology · 2005 · 153 citations

Breast Oncology, Surgical Pathology, Breast Imaging +6